Quest Pharmatech Stock Beta
| QPT Stock | CAD 0.03 0.01 25.00% |
Quest PharmaTech fundamentals help investors to digest information that contributes to Quest PharmaTech's financial success or failures. It also enables traders to predict the movement of Quest Stock. The fundamental analysis module provides a way to measure Quest PharmaTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quest PharmaTech stock.
Quest | Beta |
Quest PharmaTech Company Beta Analysis
Quest PharmaTech's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Quest PharmaTech Beta | 0.15 |
Most of Quest PharmaTech's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quest PharmaTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Quest PharmaTech has a Beta of 0.152. This is 82.33% lower than that of the Biotechnology sector and 89.06% lower than that of the Health Care industry. The beta for all Canada stocks is notably lower than that of the firm.
Quest Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Quest PharmaTech's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Quest PharmaTech could also be used in its relative valuation, which is a method of valuing Quest PharmaTech by comparing valuation metrics of similar companies.Quest PharmaTech is currently under evaluation in beta category among its peers.
As returns on the market increase, Quest PharmaTech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Quest PharmaTech is expected to be smaller as well.
Quest Fundamentals
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.0197 | ||||
| Current Valuation | 7.44 M | ||||
| Shares Outstanding | 169.13 M | ||||
| Shares Owned By Insiders | 17.06 % | ||||
| Number Of Shares Shorted | 709 | ||||
| Price To Earning | (3.09) X | ||||
| Price To Book | 0.29 X | ||||
| Price To Sales | 515.97 X | ||||
| EBITDA | (802.41 K) | ||||
| Net Income | (3.02 M) | ||||
| Cash And Equivalents | 4.41 M | ||||
| Cash Per Share | 0.03 X | ||||
| Total Debt | 1000 K | ||||
| Current Ratio | 0.40 X | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (342.42 K) | ||||
| Short Ratio | 0.02 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Beta | 0.15 | ||||
| Market Capitalization | 6.77 M | ||||
| Total Asset | 24.48 M | ||||
| Retained Earnings | (19.08 M) | ||||
| Working Capital | (487.25 K) | ||||
| Five Year Return | 32.58 % | ||||
| Net Asset | 24.48 M |
About Quest PharmaTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Quest PharmaTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quest PharmaTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quest PharmaTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Quest Stock Analysis
When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.